Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
NEA Management Company, LLC (CIK 1512848) reported $1.76B across 25 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: ACLX ($349.7M, 19.88%), CELC ($260.9M, 14.83%), ($191.5M, 10.89%), TRVI ($157.7M, 8.97%), SVRA ($133.6M, 7.60%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ACLX | Arcellx, Inc. | $349.7M | 19.88% | 3.0M | Hold |
| 2 | CELC | Celcuity Inc. | $260.9M | 14.83% | 2.3M | Trimmed |
| 3 | Spyglass Pharma, Inc. | $191.5M | 10.89% | 7.4M | New | |
| 4 | TRVI | Trevi Therapeutics, Inc. | $157.7M | 8.97% | 13.2M | Hold |
| 5 | SVRA | Savara, Inc. | $133.6M | 7.60% | 24.5M | Hold |
| 6 | GLUE | Monte Rosa Therapeutics, Inc. | $126.5M | 7.19% | 7.7M | Hold |
| 7 | MBX | MBX Biosciences, Inc. | $107.9M | 6.13% | 3.6M | Hold |
| 8 | ZBIO | Zenas BioPharma, Inc. | $78.7M | 4.47% | 4.0M | Added |
| 9 | COUR | Coursera, Inc. | $74.9M | 4.26% | 12.9M | Hold |
| 10 | AUPH | Aurinia Pharmaceuticals, Inc. | $58.8M | 3.34% | 4.0M | Hold |
| 11 | ORIC | ORIC Pharmaceuticals, Inc. | $52.2M | 2.97% | 4.1M | Hold |
| 12 | CRSP | CRISPR Therapeutics AG | $50.4M | 2.86% | 1.1M | Hold |
| 13 | PHAT | Phathom Pharmaceuticals, Inc. | $21.8M | 1.24% | 2.0M | Hold |
| 14 | CVRX | CVRx, Inc. | $19.2M | 1.09% | 2.0M | Hold |
| 15 | KRRO | Korro Bio, Inc. | $14.7M | 0.84% | 1.3M | Added |
| 16 | XFOR | X4 Pharmaceuticals, Inc. | $13.4M | 0.76% | 3.2M | Hold |
| 17 | CSBR | Champions Oncology, Inc. | $9.9M | 0.56% | 1.7M | Hold |
| 18 | BDTX | Black Diamond Therapeutics, Inc. | $9.5M | 0.54% | 4.4M | Hold |
| 19 | IVA | Inventiva SA | $8.0M | 0.46% | 1.5M | Hold |
| 20 | NKTX | Nkarta, Inc. | $7.5M | 0.43% | 3.6M | Hold |
| 21 | ATHA | LeonaBio, Inc. | $4.8M | 0.27% | 464,398 | Hold |
| 22 | SNTI | Senti Biosciences, Inc. | $3.1M | 0.17% | 3.8M | Hold |
| 23 | MRKR | Marker Therapeutics, Inc. | $2.1M | 0.12% | 1.6M | Hold |
| 24 | OKUR | OnKure Therapeutics, Inc. | $2.0M | 0.11% | 478,548 | Hold |
| 25 | GOSS | Gossamer Bio, Inc. | $328,500 | 0.02% | 1.0M | Trimmed |
Source: SEC Form 13F filings · as of 2026-03-31